Comparison of twice-daily vs once-daily deferasirox dosing in a gerbil model of iron cardiomyopathy. (Q33944180)

30 July 2017

title

Comparison of twice-daily vs once-daily deferasirox dosing in a gerbil model of iron cardiomyopathy. (English)

1 reference

30 July 2017

Maya Otto-Duessel

1

1 reference

30 July 2017

Michelle Aguilar

2

1 reference

30 July 2017

Hanspeter Nick

3

1 reference

30 July 2017

Rex Moats

4

1 reference

30 July 2017

John C Wood

5

1 reference

30 July 2017

publication date

1 July 2007

1 reference

30 July 2017

published in

Experimental Hematology

1 reference

30 July 2017

volume

35

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

1069-1073

1 reference

Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892931

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892931

ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892931

Survival and disease complications in thalassemia major.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892931

In vitro blood distribution and plasma protein binding of the iron chelator deferasirox (ICL670) and its iron complex Fe-[ICL670]2 for rat, marmoset, rabbit, mouse, dog, and human

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892931

Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892931

High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2892931

Chelation therapy and cardiac status in older patients with thalassemia major

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17588475

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17588475

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Iron chelation therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17588475

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.EXPHEM.2007.04.001

1 reference

30 July 2017

1 reference

30 July 2017

1 reference